These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 8388314)

  • 1. Antinociception produced by receptor selective opioids. Modulation of supraspinal antinociceptive effects by spinal opioids.
    Miaskowski C; Taiwo YO; Levine JD
    Brain Res; 1993 Apr; 608(1):87-94. PubMed ID: 8388314
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antinociception produced by receptor selective opioids: modulation of spinal antinociceptive effects by supraspinal opioids.
    Miaskowski C; Levine JD
    Brain Res; 1992 Nov; 595(1):32-8. PubMed ID: 1334770
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antinociceptive and motor effects of delta/mu and kappa/mu combinations of intrathecal opioid agonists.
    Miaskowski C; Sutters KA; Taiwo YO; Levine JD
    Pain; 1992 Apr; 49(1):137-144. PubMed ID: 1317544
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Contribution of supraspinal mu- and delta-opioid receptors to antinociception in the rat.
    Miaskowski C; Taiwo YO; Levine JD
    Eur J Pharmacol; 1991 Dec; 205(3):247-52. PubMed ID: 1667910
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dissociation of antinociceptive and motor effects of supraspinal opioid agonists in the rat.
    Franck LS; Miaskowski C; Putris J; Levine JD
    Brain Res; 1991 Nov; 563(1-2):123-6. PubMed ID: 1664771
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of spinal opioid analgesia by supraspinal administration of selective opioid antagonists.
    Miaskowski C; Levine JD
    Brain Res; 1992 Nov; 596(1-2):41-5. PubMed ID: 1361418
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Involvement of adenosine in antinociception produced by spinal or supraspinal receptor-selective opioid agonists: dissociation from gastrointestinal effects in mice.
    DeLander GE; Mosberg HI; Porreca F
    J Pharmacol Exp Ther; 1992 Dec; 263(3):1097-104. PubMed ID: 1335055
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Delta opioid receptor enhancement of mu opioid receptor-induced antinociception in spinal cord.
    He L; Lee NM
    J Pharmacol Exp Ther; 1998 Jun; 285(3):1181-6. PubMed ID: 9618421
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Streptozotocin-induced diabetes selectively alters the potency of analgesia produced by mu-opioid agonists, but not by delta- and kappa-opioid agonists.
    Kamei J; Ohhashi Y; Aoki T; Kawasima N; Kasuya Y
    Brain Res; 1992 Feb; 571(2):199-203. PubMed ID: 1319265
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Opioid delta-receptor involvement in supraspinal and spinal antinociception in mice.
    Heyman JS; Mulvaney SA; Mosberg HI; Porreca F
    Brain Res; 1987 Sep; 420(1):100-8. PubMed ID: 2823970
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Supraspinal antinociceptive response to [D-Pen(2,5)]-enkephalin (DPDPE) is pharmacologically distinct from that to other delta-agonists in the rat.
    Fraser GL; Pradhan AA; Clarke PB; Wahlestedt C
    J Pharmacol Exp Ther; 2000 Dec; 295(3):1135-41. PubMed ID: 11082450
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multiplicative interaction between intrathecally and intracerebroventricularly administered mu opioid agonists but limited interactions between delta and kappa agonists for antinociception in mice.
    Roerig SC; Fujimoto JM
    J Pharmacol Exp Ther; 1989 Jun; 249(3):762-8. PubMed ID: 2567350
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antinociception and delta-1 opioid receptors in the rat spinal cord: studies with intrathecal 7-benzylidenenaltrexone.
    Hammond DL; Stewart PE; Littell L
    J Pharmacol Exp Ther; 1995 Sep; 274(3):1317-24. PubMed ID: 7562504
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of the antinociceptive and motor effects of intrathecal opioid agonists in the rat.
    Miaskowski C; Sutters KA; Taiwo YO; Levine JD
    Brain Res; 1991 Jul; 553(1):105-9. PubMed ID: 1933267
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Spinal opioid receptors and adenosine release: neurochemical and behavioral characterization of opioid subtypes.
    Cahill CM; White TD; Sawynok J
    J Pharmacol Exp Ther; 1995 Oct; 275(1):84-93. PubMed ID: 7562600
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Supraspinal delta 2 opioid agonist analgesia in Swiss-Webster mice involves spinal GABAA receptors.
    Rady JJ; Fujimoto JM
    Pharmacol Biochem Behav; 1996 Jun; 54(2):363-9. PubMed ID: 8743596
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of histamine receptor antagonists injected intrathecally on antinociception induced by opioids administered intracerebroventricularly in the mouse.
    Suh HW; Chung KM; Kim YH; Huh SO; Song DK
    Neuropeptides; 1999 Apr; 33(2):121-9. PubMed ID: 10657481
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tonic pain perception in the mouse: differential modulation by three receptor-selective opioid agonists.
    Murray CW; Cowan A
    J Pharmacol Exp Ther; 1991 Apr; 257(1):335-41. PubMed ID: 1850470
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential effects of intrathecally administered delta and mu opioid receptor agonists on formalin-evoked nociception and on the expression of Fos-like immunoreactivity in the spinal cord of the rat.
    Hammond DL; Wang H; Nakashima N; Basbaum AI
    J Pharmacol Exp Ther; 1998 Jan; 284(1):378-87. PubMed ID: 9435201
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analgesic synergy and improved motor function produced by combinations of mu-delta- and mu-kappa-opioids.
    Sutters KA; Miaskowski C; Taiwo YO; Levine JD
    Brain Res; 1990 Oct; 530(2):290-4. PubMed ID: 1979930
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.